28.96 
0.29(0.99%) May 17, 4:00PM EDT|After Hours
:
28.99 0.03 (0.10%) May 17, 6:53PM EDT
| Prev Close: | 29.25 |
|---|
| Open: | 29.19 |
|---|
| Bid: | 28.60 x 1000 |
|---|
| Ask: | 28.99 x 10000 |
|---|
| 1y Target Est: | 31.47 |
|---|
| Beta: | 0.81 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 28.83 - 29.37 |
|---|
| 52wk Range: | 21.40 - 31.15 |
|---|
| Volume: | 37,642,372 |
|---|
| Avg Vol (3m): | 32,209,800 |
|---|
| Market Cap: | 205.42B |
|---|
| P/E (ttm): | 13.86 |
|---|
| EPS (ttm): | 2.09 |
|---|
| Div & Yield: | 0.96 (3.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Dow Jumps on Virtuous Cycleat Motley Fool(Fri, May 17)
- Industrial Stocks Drive Dow’s 112-Point Dayat Motley Fool(Fri, May 17)
- Final Glance: Pharmaceuticals companiesAP(Fri, May 17)
- JPMorgan: S&P at 1,715at Barrons.com(Fri, May 17)
- Midday Glance: Pharmaceuticals companiesAP(Fri, May 17)
- [video] Google Wallet: Gen Y Credit Card?at MarketWatch(Fri, May 17)
- PFIZER INC FinancialsEDGAR Online Financials(Fri, May 17)
- Disney CFO Sells More Than 217K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Fri, May 17)
- Pfizer Executive VP Sells 100K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Fri, May 17)
- Stanley Druckenmiller's top stock picksat MarketWatch(Fri, May 17)
- Diagnosing Alzheimer's Firstat Motley Fool(Fri, May 17)
- Early Glance: Pharmaceuticals companiesAP(Fri, May 17)
- Any Light at the End of the Tunnel for Alzheimer's Disease?at Motley Fool(Thu, May 16)
- Halozyme rises on pancreatic cancer drug studyAP(Thu, May 16)
- Halozyme rises on prostate cancer drug studyAP(Thu, May 16)
Key Statistics
| Forward P/E (1 yr): | 12.32 |
|---|
| P/S (ttm): | 3.60 |
|---|
| Ex-Dividend Date: | 08-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.21 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.58 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 4.73 |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More